Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jiajian Yishen Xiaozheng Qufeng Granules for Diabetic Nephropathy
NCT07459946Not yet recruiting
- Sponsor
- Jiazhen Yin
- Start
- Mar 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of Jiajian Yishen Xiaozheng Qufeng Granules in diabetic nephropathy (DN) (2 arms), sponsored by Jiazhen Yin. Primary endpoint: UACR/UAER/24-hour urinary protein returns to normal or decreases by 50% at 24 weeks. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
Jiajian Yishen Xiaozheng Qufeng Granules
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT07459946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07459946.